Core Viewpoint - The company, Yaxiang Co., Ltd. (301220.SZ), reported that its factory in Thailand is currently operating well, with sufficient orders to support normal operations, including the production and sales of various products such as natural leaf alcohol and moss [1] Group 1 - The Thai factory is in good operational condition [1] - There are enough orders on hand to sustain the factory's normal operations [1] - Various product categories, including natural leaf alcohol and moss, are being produced and shipped in an orderly manner [1]

Core Viewpoint - The company has confirmed that its Thai factory is operating well, with sufficient orders to support normal operations, including the production and sales of key products like natural leaf alcohol and rubber moss [1] Group 1: Company Operations - The Thai factory's output value is reported to be 800 million, with a net increase of 500 million [1] - The company anticipates an annual revenue of 1.2 billion based on the 2024 revenue calculations, excluding the second phase of operations [1] - The production capacity utilization of the Thai production line has been noted as low, particularly for key products such as leaf alcohol and rubber moss, which have not yet reached large-scale production [1] Group 2: Order and Production Status - The company stated that it has enough existing orders to ensure the factory operates normally [1] - Production and sales of various product categories, including natural leaf alcohol and rubber moss, are ongoing and being executed in an orderly manner [1]

Core Viewpoint - The company has experienced significant revenue growth in 2024, but net profit has declined due to intense price competition in the spice industry [2] Group 1: Financial Performance - In 2024, the company achieved a revenue of 797 million yuan, representing a year-on-year increase of 26.42%, while net profit attributable to shareholders was 56 million yuan, down 30.51% [2] - In Q1 2024, the company reported a record revenue of 262 million yuan and a net profit of approximately 82.17 million yuan, with a non-recurring net profit of 38.20 million yuan, marking a year-on-year growth of 120.8% [2] Group 2: Production Capacity and Expansion - The first phase of the "Yaxiang Biotechnology (Thailand) Co., Ltd. Production Base Project" commenced production in November 2024, with the Thai factory achieving normal full-load production [2] - The first phase capacity includes 1,000 tons of vanillin, 200 tons of oak moss, and other products, with a second phase expected to be completed around August 2025 [3] - A new synthetic vanillin production line is planned in Thailand, which will have an annual capacity of 4,000 tons [3] Group 3: Strategic Investments - The company plans to acquire 10% equity in Centrome Inc. for 30 million USD to expand sales channels and market share in the U.S. [3] - This investment is expected to enhance the company's international influence and complement its U.S. subsidiary's operations [3] Group 4: Market Strategy - The establishment of the Thai base allows the company to diversify its product structure and increase production capacity while avoiding tariff impacts [4] - The company is actively exploring new product layouts to meet diverse market demands, including the introduction of ambroxan, a fragrance ingredient commonly used in perfumes [4]